Summary
Forty-one assays were analysed at the 3rd International Workshop on the standardisation of islet cell antibodies. Analysis of precision demonstrated assays consistently detecting blind duplicates within one doubling dilution and capable of discriminating one doubling dilution differences in islet cell antibody concentration. Some assays, however, reported duplicates discrepantly by more than seven doubling dilutions, and consequently could not distinguish even large quantities of islet cell antibodies. Precision was best in assays from laboratories which had participated in all three Standardisation Workshops and was not dependent upon methodology. The use of the Juvenile, Diabetes Foundation reference islet cell antibody standard and standard curves reduced the scatter of results, and was best amongst assays with better precision. Twenty-seven assays reported all ten blood donor sera as negative. However, 14 assays did not, and specificity (negativity in health) was <50% in three assays. Low specificity was strongly associated with poor precision. The detection limit of assays ranged from <5 to 50 JDF units and was partially dependent upon methodology. Assays incorporating extended incubation had the lowest detection limits without a decrease in the specificity of the ten blood donor sera. Precise quantification is fundamental for the standardisation and comparability of islet cell antibodies. Precise quantitative assays have been identified and reference standards and common units established.
Article PDF
Similar content being viewed by others
References
Tarn AC, Thomas JM, Dean BM, Ingram D, Schwarz G, Bottazzo GF, Gale EAM (1988) Predicting insulin-dependent diabetes. Lancet I: 845–850
Srikanta S, Ganda OP, Rabizadeh A, Soeldner SJ, Eisenbarth GS (1985) First-degree relatives of patients with type 1 diabetes mellitus: islet-cell antibodies and abnormal insulin secretion. N Engl J Med 313: 461–464
Bruining GJ, Molenaar JL, Grobbe DE, Hofman A, Scheffer GJ, Bruining HA, De Bruyn AM, Valkenburg HA (1989) Ten-year follow-up study of islet cell antibodies and childhood diabetes mellitus. Lancet I: 1100–1103
Groop LC, Bottazzo GF, Doniach D (1986) Islet cell antibodies identify latent type 1 diabetes in patients aged 35–75 years at diagnosis. Diabetes 35: 237–241
Irvine WJ, Sawers JSA, Feck CM, Prescott RJ, Duncan LJP (1979) The value of islet cell antibody in predicting secondary failure of oral hypoglycaemic agent therapy in diabetes mellitus. J Clin Lab Immunol 2: 23–26
Gleichmann H, Zorcher B, Grenlich B, Gries FA, Henrichs HR, Bertrams J, Kolb H (1984) Correlation of islet cell antibodies and HLA-DR phenotypes with diabetes mellitus in adults. Diabetologia 27: 90–92
Marner B, Agner T, Binder C, Lernmark Å, Nerup J, Mandrup-Pousen T, Walldorff S (1985) Increased reduction in fasting C-peptide is associated with islet cell antibodies in Type 1 (insulin-dependent) diabetic patients. Diabetologia 28: 875–880
Wallenstein M, Dahlquist G, Persson B, Landin-Olsson M, Lernmark Å, Sundkvist G, Thalme B (1988) Factors influencing the magnitude, duration, and rate of fall of B cell function in Type 1 (insulin-dependent) diabetic children followed for two years from their clinical diagnosis. Diabetologia 31: 664–669
Mandrup-Poulsen T, Nerup J, Stiller CR, Marner B, Bille G, Heinrichs D, Martell R, Dupre J, Keown PA, Jenner MR, Rodger NW, Wolfe B, Graffenried BC, Binder C (1985) Disappearance and reappearance of islet cell cytoplasmic antibodies in cyclosporin-treated insulin-dependent diabetics. Lancet 1: 599–506
Boitard C, Feutren G, Castano L, Debray-Sachs M, Aisan R, Hors J, Bach JF (1987) Effect of cyclosporin A treatment on the production of antibody in insulin-dependent (type 1) diabetic patients. J Clin Invest 80: 1607–1612
Bottazzo GF, Florin-Christensen A, Doniach D (1974) Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 2: 1279–1283
Pilcher C, Elliot RB (1984) Improved sensitivity of islet cell cytoplasmic antibody assay in diabetics (Letter). Lancet 1: 1352
Madsen OD, Landin Olsson M, Bille G, Sundkvist G, Lernmark Å, Dahlquist G, Ludvigsson J (1986) A two-colour immunofluorescence test with a monoclonal human proinsulin antibody improves the assay for islet cell antibodies. Diabetologia 29: 115–118
Srikanta S, Rabizadeh A, Omar MAK, Eisenbarth GS (1985) Assay for islet cell antibodies: protein A-monocloncal antibody method. Diabetes 34: 300–305
Kobayashi T, Sugimoto T, Itoh T, Kosaka K, Suwa S, Sato K, Tsuji K (1986) The prevalence of islet cell antibodies in Japanese insulin-dependent and non-insulin dependent diabetic patients studied by indirect immunofluorescence and by a new method. Diabetes 35: 335–340
Krell J, Rabin BS (1984) Comparison of an immunohistochemical and immunofluorescence procedure to detect antibody to pancreatic islet cells. Diabetes 33: 709–711
Bottazzo GF, Dean BM, Gorsuch AN, Cudworth AG, Doniach D (1980) Complement-fixing islet-cell antibodies in type-1 diabetes: possible monitors of active beta-cell damage. Lancet 1: 668–672
Dib SA, Colman PG, Dotta F, Tautkus M, Rabizadeh A, Eisenbarth GS (1987) Expression of cytoplasmic islet cell antigens by rat pancreas. Diabetes 36: 982–985
Bottazzo GF, Gleichmann H (1986) Immunology and Diabetes Workshops: Report of the First International Workshop on the Standardisation of Cytoplasmic Islet Cell Antibodies. Diabetologia 29: 125–126
Bonifacio E, Lernmark Å, Dawkins RL (1988) Serum exchange and the use of dilutions have improved precision of measurement of islet cell antibodies. J Immunol Methods 106: 83–85
Gleichmann H, Bottazzo GF (1987) Islet cell and insulin autoantibodies in diabetes. Immunol Today 8: 167–168
Boitard C, Bonifacio E, Bottazzo GF, Gleichmann H, Molenaar J (1988) Immunology and Diabetes Workshop: Report on the Third International (Stage 3) Workshop on the Standardisation of Cytoplasmic Islet Cell Antibodies. Diabetologia 31: 451–452
Bonifacio E, Hollingsworth PN, Dawkins RL (1986) Antinuclear antibody: precise and accurate quantitation without serial dilution. J Immunol Methods 91: 249–255
Marner B, Lernmark Å, Nerup J, Molenaar JL, Tuk CW, Bruin-ing GJ (1986) Analysis of islet cell antibodies on frozen sections of human pancreas. Diabetologia 25: 93–96
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bonifacio, E., Boitard, C., Gleichmann, H. et al. Assessment of precision, concordance, specificity, and sensitivity of islet cell antibody measurement in 41 assays. Diabetologia 33, 731–736 (1990). https://doi.org/10.1007/BF00400345
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00400345